B Braun Company Profile
✉ Email this page to a colleague
What is the competitive landscape for B BRAUN, and what generic alternatives to B BRAUN drugs are available?
B BRAUN has one hundred and seventeen approved drugs.
There are two US patents protecting B BRAUN drugs.
There are twenty-seven patent family members on B BRAUN drugs in twenty-seven countries and two hundred and thirty-six supplementary protection certificates in sixteen countries.
Summary for B Braun
| International Patents: | 27 |
| US Patents: | 2 |
| Tradenames: | 225 |
| Ingredients: | 63 |
| NDAs: | 117 |
Drugs and US Patents for B Braun
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B Braun | POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% IN PLASTIC CONTAINER | dextrose; potassium chloride | INJECTABLE;INJECTION | 018744-001 | Nov 9, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| B Braun | MANNITOL 20% IN PLASTIC CONTAINER | mannitol | INJECTABLE;INJECTION | 020006-004 | Jul 26, 1993 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| B Braun | CEFAZOLIN AND DEXTROSE | cefazolin sodium | INJECTABLE;INJECTION | 050779-002 | Jul 27, 2000 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for B Braun
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| B Braun | HEPATAMINE 8% | amino acids | INJECTABLE;INJECTION | 018676-001 | Aug 3, 1982 | 3,950,529 | ⤷ Try a Trial |
| B Braun | UCEPHAN | sodium benzoate; sodium phenylacetate | SOLUTION;ORAL | 019530-001 | Dec 23, 1987 | 4,284,647 | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for B Braun Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Spain | 2441790 | ⤷ Try a Trial |
| Mexico | 2015007288 | ⤷ Try a Trial |
| World Intellectual Property Organization (WIPO) | 2014091420 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for B Braun Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2673237 | 1990016-6 | Sweden | ⤷ Try a Trial | PRODUCT NAME: SODIUM ZIRCONIUM CYCLOSILICATE; REG. NO/DATE: EU/1/17/1173 20180326 |
| 2404919 | C02404919/01 | Switzerland | ⤷ Try a Trial | PRODUCT NAME: 3-(6-((1-(2,2-DIFLUOR-1,3-BENZODIOXOL-5-YL)CYCLOPROPANCARBONYL)AMINO)-3-METHYLPYRIDIN-2-YL)BENZOESAEURE (LUMACAFTOR); REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 65981 02.09.2016 |
| 1713823 | 1490064-1 | Sweden | ⤷ Try a Trial | PRODUCT NAME: SIMEPREVIR, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, INCLUDING SIMEPREVIR SODIUM; REG. NO/DATE: EU/1/14/924 20140516 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
